794 reports of this reaction
3.4% of all PATIROMER reports
#6 most reported adverse reaction
BLOOD POTASSIUM INCREASED is the #6 most commonly reported adverse reaction for PATIROMER, manufactured by Vifor Pharma, Inc.. There are 794 FDA adverse event reports linking PATIROMER to BLOOD POTASSIUM INCREASED. This represents approximately 3.4% of all 23,545 adverse event reports for this drug.
Patients taking PATIROMER who experience blood potassium increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD POTASSIUM INCREASED is moderately reported among PATIROMER users, representing a notable but not dominant share of adverse events.
In addition to blood potassium increased, the following adverse reactions have been reported for PATIROMER:
The following drugs have also been linked to blood potassium increased in FDA adverse event reports:
BLOOD POTASSIUM INCREASED has been reported as an adverse event in 794 FDA reports for PATIROMER. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD POTASSIUM INCREASED accounts for approximately 3.4% of all adverse event reports for PATIROMER, making it a notable side effect.
If you experience blood potassium increased while taking PATIROMER, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.